Cart (0 Items)
Your cart is currently empty.
View ProductsNamilumab Biosimilar – Anti-CSF2, GM-CSF mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Namilumab Biosimilar - Anti-CSF2, GM-CSF mAb - Research Grade |
|---|---|
| Source | CAS 1206681-39-1 |
| Species | Homo sapiens |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Applications | ELISA,WB |
| Aliases /Synonyms | Namilumab,MT203,CSF2, GM-CSF,anti-CSF2, GM-CSF |
| Reference | PX-TA1259 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Namilumab Biosimilar - Anti-CSF2/GM-CSF mAb - Research Grade
General information on Anti-CSF2/GM-CSF[Homo sapiens] (Namilumab) Monoclonal Antibody
Namilumab has beeninvestigated for the treatment of Plaque Psoriasis and Rheumatoid Arthritis.
Namilumab Biosimilar - Anti-CSF2, GM-CSF mAb binds to Human CSF2/GM-CSF in indirect ELISA Assay
Immobilized CSF2 / GM-CSF (in Mammalian), C-His, recombinant protein (cat. No. PX-P5667) at 0.5µg/mL (100µL/well) can bind Namilumab Biosimilar - Anti-CSF2, GM-CSF mAb (cat. No. PX-TA1259) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450 giving an EC50 at 34.24M.
Related products
Antigen
Granulocyte-macrophage colony-stimulating factor receptor subunit alpha(CSF2RA)
PX-P4584 210€
Antigen
CD131 recombinant protein
PX-P4896 210€
Antigen
CD116 / CSF2RA, C-His, recombinant protein
PX-P5550 385€
Antigen
CSF2 / GM-CSF (in E.coli), C-His, recombinant protein
PX-P5666 385€
SIL
Stable Isotope Labelled Namilumab Biosimilar – Anti-CSF2/GM-CSF mAb – Research Grade
PX-TA1259-SIL 15000€
ELISA
Reviews
Il n’y a pas encore d’avis.